{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T19:10:04Z","timestamp":1746990604373,"version":"3.40.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,11]]},"DOI":"10.7759\/cureus.83910","type":"journal-article","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T18:36:22Z","timestamp":1746988582000},"source":"Crossref","is-referenced-by-count":0,"title":["Heparin-Induced Thrombocytopenia in a Patient With Pulmonary Embolism and Bilateral Deep Venous Thrombosis: A Case Report"],"prefix":"10.7759","author":[{"given":"Blessing T","family":"Ojinna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arshia","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lela","family":"Adeoshun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zia H","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.02.073","article-title":"Heparin-induced thrombocytopenia: a comprehensive clinical review","volume":"67","author":"Salter BS","year":"2016","unstructured":"Salter BS, Weiner MM, Trinh MA, Heller J, Evans AS, Adams DH, Fischer GW. Heparin-induced thrombocytopenia: a comprehensive clinical review. J Am Coll Cardiol. 2016, 67:2519-32. 10.1016\/j.jacc.2016.02.073","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10040683","article-title":"Heparin-induced thrombocytopenia: a review of new concepts in pathogenesis, diagnosis, and management","volume":"10","author":"Marchetti M","year":"2021","unstructured":"Marchetti M, Zermatten MG, Bertaggia Calderara D, Aliotta A, Alberio L. Heparin-induced thrombocytopenia: a review of new concepts in pathogenesis, diagnosis, and management. J Clin Med. 2021, 10:683. 10.3390\/jcm10040683","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2020.04.014","article-title":"Pathogenesis of heparin-induced thrombocytopenia","volume":"225","author":"Arepally GM","year":"2020","unstructured":"Arepally GM, Cines DB. Pathogenesis of heparin-induced thrombocytopenia. Transl Res. 2020, 225:131-40. 10.1016\/j.trsl.2020.04.014","journal-title":"Transl Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30046-2","article-title":"Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study","volume":"5","author":"Dhakal B","year":"2018","unstructured":"Dhakal B, Kreuziger LB, Rein L, et al.. Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study. Lancet Haematol. 2018, 5:e220-31. 10.1016\/S2352-3026(18)30046-2","journal-title":"Lancet Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/1076029615578167","article-title":"Heparin reexposure in patients with a history of heparin-induced thrombocytopenia","volume":"21","author":"Dhakal P","year":"2015","unstructured":"Dhakal P, Giri S, Pathak R, Bhatt VR. Heparin reexposure in patients with a history of heparin-induced thrombocytopenia. Clin Appl Thromb Hemost. 2015, 21:626-31. 10.1177\/1076029615578167","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X19898253","article-title":"Heparin-induced thrombocytopenia (HIT): review of incidence, diagnosis, and management","volume":"25","author":"Hogan M","year":"2020","unstructured":"Hogan M, Berger JS. Heparin-induced thrombocytopenia (HIT): review of incidence, diagnosis, and management. Vasc Med. 2020, 25:160-73. 10.1177\/1358863X19898253","journal-title":"Vasc Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(98)00134-x","article-title":"Heparin-induced thrombocytopenia","volume":"31","author":"Brieger DB","year":"1998","unstructured":"Brieger DB, Mak KH, Kottke-Marchant K, et al.. Heparin-induced thrombocytopenia. J Am College Cardiol. 1998, 31:1449-59. 10.1016\/s0735-1097(98)00134-x","journal-title":"J Am College Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2020.03.012","article-title":"Diagnosis and management of heparin-induced thrombocytopenia","volume":"39","author":"Gruel Y","year":"2020","unstructured":"Gruel Y, De Maistre E, Pouplard C, et al.. Diagnosis and management of heparin-induced thrombocytopenia. Anaesth Crit Care Pain Med. 2020, 39:291-310. 10.1016\/j.accpm.2020.03.012","journal-title":"Anaesth Crit Care Pain Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.5.1703","article-title":"Impact of the patient population on the risk for heparin-induced thrombocytopenia","volume":"96","author":"Warkentin TE","year":"2000","unstructured":"Warkentin TE, Sheppard J, Horsewood P, et al.. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood. 2000, 96:1703-8. 10.1182\/blood.V96.5.1703","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X17714340","article-title":"Heparin-induced thrombocytopenia (HIT)","volume":"22","author":"Evans NS","year":"2017","unstructured":"Evans NS, Gomes M. Heparin-induced thrombocytopenia (HIT). Vasc Med. 2017, 22:353-5. 10.1177\/1358863X17714340","journal-title":"Vasc Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2001.1.282","article-title":"Platelets: an update on diagnosis and management of thrombocytopenic disorders","author":"McCrae KR","year":"2001","unstructured":"McCrae KR, Bussel JB, Mannucci PM, Remuzzi G, Cines DB. Platelets: an update on diagnosis and management of thrombocytopenic disorders. Hematol Am Soc Hematol Educ Program. 2001, 282-305. 10.1182\/asheducation-2001.1.282","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13031","article-title":"Timeline of heparin-induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay","volume":"41","author":"Warkentin TE","year":"2019","unstructured":"Warkentin TE, Sheppard JI, Smith JW, Arnold DM, Nazy I. Timeline of heparin-induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay. Int J Lab Hematol. 2019, 41:493-502. 10.1111\/ijlh.13031","journal-title":"Int J Lab Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13340","article-title":"Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?","volume":"83","author":"Leentjens J","year":"2017","unstructured":"Leentjens J, Peters M, Esselink AC, Smulders Y, Kramers C. Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?. Br J Clin Pharmacol. 2017, 83:2356-66. 10.1111\/bcp.13340","journal-title":"Br J Clin Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.06.005","article-title":"Heparin-induced thrombocytopenia: clinical manifestations and management strategies","volume":"118 Suppl 8A","author":"Menajovsky LB","year":"2005","unstructured":"Menajovsky LB. Heparin-induced thrombocytopenia: clinical manifestations and management strategies. Am J Med. 2005, 118 Suppl 8A:21S-30S. 10.1016\/j.amjmed.2005.06.005","journal-title":"Am J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2007.06.004","article-title":"Heparin-induced thrombocytopenia","volume":"21","author":"Warkentin TE","year":"2007","unstructured":"Warkentin TE. Heparin-induced thrombocytopenia. Hematol Oncol Clin North Am. 2007, 21:589-607. 10.1016\/j.hoc.2007.06.004","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker A","year":"2018","unstructured":"Cuker A, Arepally GM, Chong BH, et al.. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018, 2:3360-92. 10.1182\/bloodadvances.2018024489","journal-title":"Blood Adv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/361344-heparin-induced-thrombocytopenia-in-a-patient-with-pulmonary-embolism-and-bilateral-deep-venous-thrombosis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T18:36:22Z","timestamp":1746988582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/361344-heparin-induced-thrombocytopenia-in-a-patient-with-pulmonary-embolism-and-bilateral-deep-venous-thrombosis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,11]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.83910","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,11]]}}}